相关实验视频
Updated: Jan 12, 2026

09:15
In Vitro Thrombosis Test for Ventricular Assist Devices
Published on: March 21, 2025
1.1K
在使用直接口服抗凝剂的患者中进行凝血检测的ADLM指导文件
Lindsay A L Bazydlo1, Maximo J Marin2, Anna E Merrill3
1Department of Pathology, University of Virginia, Charlottesville, VA, United States.
The journal of applied laboratory medicine
|November 5, 2025
概括
直接口服抗凝剂 (DOAC) 简化了治疗,但影响了凝血测试. 本指南有助于解释结果并管理DOAC患者的测试,确保准确的血液静止评估.
科学领域:
- 临床化学 临床化学
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 凝血检测对于诊断和管理血液静止障碍至关重要.
- 直接口服抗凝剂 (DOAC) 提供了方便的抗凝剂,但对标准实验室检测提出了挑战.
- 了解DOAC干扰对于准确的患者评估至关重要.
研究的目的:
- 为受DOACs影响的凝血试验提供指导.
- 讨论减轻测试中DOAC干扰的方法.
- 概述测试和解释DOAC度的策略.
主要方法:
- 对DOAC对凝血试验影响的文献综述.
- 分析特定的凝血试验及其对DOACs的敏感性.
- 对缓解策略的评估和度测试.
主要成果:
- 某些凝血试验受到DOACs的显著影响,可能导致不准确的结果.
- 特定的协议可以减轻DOAC干扰,允许可靠的测试.
- 现有方法可以量化DOAC度,用于临床解释.
结论:
- 在服用DOAC的患者中进行凝血测试需要仔细考虑药物干扰.
- 适当的测试策略和解释对于患者护理至关重要.
- 本指南有助于临床医生在DOAC治疗中应对凝血测试的复杂性.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Venous Thrombosis III: Interprofessional Care
273
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
273
Coagulation
9.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
9.6K
Coagulation
1.2K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.2K
Disorders of Hemostasis
2.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.0K

